AI-assisted summary

Missouri's Attorney General is challenging the FDA's approval of a new generic mifepristone brand.

The legal action seeks to restore previous restrictions, including in-person doctor visits and a shorter usage window.

Medication abortion, which involves mifepristone, is used in approximately two-thirds of all U.S. abortions.

Missouri Attorney General Catherine Hanaway is asking a federal court to roll back the U.S. Food and Drug Administration’s recent decision to approve a new generic brand of mifepristone, her first foray into a lawsuit filed by her predecessor to limit access to medication abortion nationwide.

In September the FDA approved a new generic form of mifepristone , bringing the total approved manufacturers to three.

This federal approval, which dr

See Full Page